BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 33255396)

  • 1. Bypassing the Blood-Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies.
    Gernert M; Feja M
    Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33255396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.
    Löscher W; Potschka H; Sisodiya SM; Vezzani A
    Pharmacol Rev; 2020 Jul; 72(3):606-638. PubMed ID: 32540959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting antiseizure effects of chronic intrasubthalamic convection-enhanced delivery of valproate.
    MacKeigan D; Feja M; Meller S; Deking L; Javadova A; Veenhuis A; Felmy F; Gernert M
    Neurobiol Dis; 2023 Oct; 187():106321. PubMed ID: 37832796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic convection-enhanced muscimol delivery into the rat subthalamic nucleus induces antiseizure effects associated with high responder rates.
    Gernert M; MacKeigan D; Deking L; Kaczmarek E; Feja M
    Epilepsy Res; 2023 Feb; 190():107097. PubMed ID: 36736200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers.
    Tang F; Hartz AMS; Bauer B
    Front Neurol; 2017; 8():301. PubMed ID: 28729850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigabatrin for focal drug delivery in epilepsy: bilateral microinfusion into the subthalamic nucleus is more effective than intranigral or systemic administration in a rat seizure model.
    Bröer S; Backofen-Wehrhahn B; Bankstahl M; Gey L; Gernert M; Löscher W
    Neurobiol Dis; 2012 May; 46(2):362-76. PubMed ID: 22342648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of blood-brain barrier in temporal lobe epilepsy and pharmacoresistance.
    van Vliet EA; Aronica E; Gorter JA
    Neuroscience; 2014 Sep; 277():455-73. PubMed ID: 25080160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular administration for delivery of antiseizure therapeutics: Challenges and opportunities.
    Fahoum F; Eyal S
    Epilepsia; 2023 Jul; 64(7):1750-1765. PubMed ID: 37086103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution and prospects for intracranial pharmacotherapy for refractory epilepsies: the subdural hybrid neuroprosthesis.
    Ludvig N; Medveczky G; French JA; Carlson C; Devinsky O; Kuzniecky RI
    Epilepsy Res Treat; 2010; 2010():725696. PubMed ID: 22937227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Animal models of epilepsy and experimental seizures].
    Bizière K; Chambon JP
    Rev Neurol (Paris); 1987; 143(5):329-40. PubMed ID: 3116633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy and the blood-brain barrier.
    Cornford EM; Oldendorf WH
    Adv Neurol; 1986; 44():787-812. PubMed ID: 3085437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.
    Cooper I; Last D; Guez D; Sharabi S; Elhaik Goldman S; Lubitz I; Daniels D; Salomon S; Tamar G; Tamir T; Mardor R; Fridkin M; Shechter Y; Mardor Y
    J Cereb Blood Flow Metab; 2015 Jun; 35(6):967-76. PubMed ID: 25669901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-demand pulsatile intracerebral delivery of carisbamate with closed-loop direct neurostimulation therapy in an electrically induced self-sustained focal-onset epilepsy rat model.
    Mangubat EZ; Kellogg RG; Harris TJ; Rossi MA
    J Neurosurg; 2015 Jun; 122(6):1283-92. PubMed ID: 25723302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraosseous administration into the skull: Potential blood-brain barrier bypassing route for brain drug delivery.
    Kang JH; Ko YT
    Bioeng Transl Med; 2023 Mar; 8(2):e10424. PubMed ID: 36925676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of the epilepsies in children.
    Cowan LD
    Ment Retard Dev Disabil Res Rev; 2002; 8(3):171-81. PubMed ID: 12216061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic epilepsies imitating idiopathic generalized epilepsies.
    Oguni H
    Epilepsia; 2005; 46 Suppl 9():84-90. PubMed ID: 16302880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interictal stereotactic-EEG functional connectivity in refractory focal epilepsies.
    Lagarde S; Roehri N; Lambert I; Trebuchon A; McGonigal A; Carron R; Scavarda D; Milh M; Pizzo F; Colombet B; Giusiano B; Medina Villalon S; Guye M; Bénar CG; Bartolomei F
    Brain; 2018 Oct; 141(10):2966-2980. PubMed ID: 30107499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS drug delivery systems: novel approaches.
    Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epileptology of the first tonic-clonic seizure in adults and prediction of seizure recurrence.
    Koutroumanidis M; Bruno E
    Epileptic Disord; 2018 Dec; 20(6):490-501. PubMed ID: 30530414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. It's All About the Networks.
    Shih JJ
    Epilepsy Curr; 2019; 19(3):165-167. PubMed ID: 31032667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.